NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) — BondWave LLC, a leading financial technology firm focused on fixed income solutions, announced today that it has completed its acquisition of Bitvore’s Fixed Income Data Analytics business. Terms of the acquisition were not disclosed. Founded in 2010, Bitvore is a leading AI company that provides some of the world’s largest financial institutions with unique business insights from unstructured data. Bitvore’s Fixed Income Data Analytics service leverages AI and machine learning technologies to sort through thousands of public news and other sources to provide targeted material data to investors in municipal bonds, providing additional transparency, and allowing users to make more informed investment decisions. The acquisition of Bitvore’s Fixed Income Data Analytics service further underscores...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LEARNING TECHNOLOGIES GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Update call scheduled for November 20th at 7:30 a.m. Eastern with anticipated close Salt Lake City USA, Oxford UK, Nov. 13, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) have each received overwhelming approval from their shareholders for the proposed combination between Recursion and Exscientia.  The transaction is expected to close on November 20, 2024, subject to the satisfaction or waiver of the remaining customary closing conditions. Recursion expects to host an update call after the anticipated close on November 20, 2024 at 7:30 a.m. ET /  5:30 a.m MT / 12:30 p.m. GMT. The company will broadcast the live stream from Recursion’s X (formerly Twitter), LinkedIn and YouTube accounts. Questions can be submitted via this link ahead of time or during the livestream. “The overwhelming support...

Westford,USA, Nov. 13, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Smart Transportation Market will reach a value of USD 293.84 Billion by 2031, with a CAGR of 13% during the forecast period (2024-2031). The expansion of the market is primarily attributed to the growing advancements in urban projects, the initiatives undertaken by the governments to mitigate the emissions of greenhouse gases, and the increasing demand for the inclusion of technology in traffic management systems. The majority of cities face serious challenges with low-quality, unsafe public transportation, insufficient management capabilities, diminished road safety concerns, ineffective traffic control, and parking issues (including pedestrian walkways). As a result, there will probably be a large increase in demand for smart transport systems soon. Download...

Westford,USA, Nov. 13, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Clear Aligners Market will reach a value of USD 43.4 Billion by 2031, with a CAGR of 30.7% during the forecast period (2024-2031). Clear aligners are witnessing a surge in popularity owing to trends like aesthetics, convenience, comfort, projected results, and improved patient experience. Moreover, the market is propelled by the growing incidences of malocclusion, the rising acceptance of orthodontic treatment among a large adult population, and technological advancements that improve the effectiveness and precision of clear aligners. In addition, the growing demand for aesthetic treatments by a larger patient population is fueling the market growth. Download a detailed overview: https://www.skyquestt.com/sample-request/clear-aligners-market Browse in-depth...

Westford,USA, Nov. 13, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Vaccines market will attain a value of USD 99.85 billion by 2031, with a CAGR of 3.70% over the forecast period (2024-2031). Surging prevalence of chronic diseases and increasing launch of new vaccination programs around the world are projected to bolster the demand for vaccines in the future. Rising investments in vaccine R&D and growing emphasis on preventive healthcare around the world are also projected to promote sales of vaccines over the coming years. Download a detailed overview:https://www.skyquestt.com/sample-request/vaccines-market Browse in-depth TOC on “Vaccines Market”Pages – 212 Tables – 147 Figures – 71Vaccines market Overview:Report Coverage DetailsMarket Revenue in 2023 $ 74.66 billionEstimated...

Westford,USA, Nov. 13, 2024 (GLOBE NEWSWIRE) — Dental Practice Management Software Market size was valued at USD 1.38 billion in 2022 and is poised to grow from USD 1.50 billion in 2023 to USD 2.90 billion by 2031, growing at a CAGR of 8.6% in the forecast period (2024-2031). The market is anticipated to grow significantly, owing to the rising dental visits, increasing focus & awareness about oral health, and the rapid technological advancement. The Health Information Technology for Economic and Clinical Health encouraged the growth while providing the use of health information technology in the United States. Moreover, the adoption of healthcare IT solutions, especially by the speciality clinics like oral practices is expected to increase insurance coverage. Hence, the above reasons are expected to result in the increased...

Proposed merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing (i) Journey’s next-gen, first-in-class ADC-rivalling, nano-immunoconjugates (“NIC”) platform and therapeutic products for unmet medical needs in oncology and autoimmune diseases and (ii) Entero’s gastrointestinal product pipeline for treating unmet metabolic and rare genetic diseases; The NIC platform technology is invented by and originated from Svetomir N. Markovic, M.D., Ph.D. of Mayo Clinic and is exclusively licensed by Journey with worldwide rights to sublicense; The NIC technology employs the cutting edge cancer drug – nanoparticle albumin-bound (“NAB”) paclitaxel Abraxane – as a therapeutic backbone, combining with (i) on-demand tumor-targeting, tumor-suppressing and/or immune checkpoint inhibitor therapeutic antibody and (ii)...

Teleradiology Market size is poised to grow from USD 9.58 billion in 2023 to USD 30.13 billion by 2031, growing at a CAGR of 15.40% during the forecast period (2024-2031). Westford, USA, Nov. 13, 2024 (GLOBE NEWSWIRE) — Global Teleradiology Market size to grow from USD 9.58 billion in 2023 to USD 30.13 billion by 2031, growing at a CAGR of 15.40% during the forecast period (2024-2031). In recent times, the Teleradiology Market is witnessing as surge due to the increasing prevalence of target diseases and growing demand for teleradiology to get second opinions during emergencies. Furthermore, the incidence of COVID-19 has also emphasized on the significance of teleradiology. The lack of medialprofessionals, particularly in the sub-specialist segment, like paediatric, neurology, and musculoskeletal radiology are resulting in the...

Growing at a CAGR of 9.84% during the forecast period (2024-2031). Westford, USA, Nov. 13, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Cell Line Development Market will reach a value of USD 15.88 Billion by 2031, with a CAGR of 12.12% during the forecast period (2024-2031). Cell line development, or CLD, will likely become popular as more and more biopharmaceutical companies start sprouting up. Cells are used as an expression host by most biopharma companies to synthesise recombinant monoclonal antibodies and proteins. The market is expected to grow in the upcoming years due to the availability of improved technologies for producing novel cell lines, as well as an increase in demand for cancer medicines and monoclonal antibodies. Download a detailed overview:https://www.skyquestt.com/sample-request/cell-line-development-market Cell...